Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 26, 2026, Wave Life Sciences Ltd. (the “Company”) announced its financial results for the quarter and
Regulation FD Disclosure. From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and
Financial Statements and Exhibits. (d) Exhibits The following exhibits relating to Items 2.02 and 7.01 are furnished and not filed: Exhibit No. Description 99.1